In HF with iron deficiency, IV ferric derisomaltose was associated with lower rates of HF hospitalization or CV death.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 37011388.
- Also identified by DOI 10.7326/J23-0012.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Kalra PR, Cleland JG, Petrie MC, et al. <b>Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial.</b> Lancet. 2022;400:2199-209. 36347265.
Medical subject headings
- Anemia, Iron-Deficiency
- Iron Deficiencies
- Heart Failure